5/27/2026 10:49:10 AM MHRA consults on draft regulatory framework for rare disease therapies By Bobbie Bickerton Alison Llewellyn On 21 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) published its draft regulatory framework for rare...
5/21/2026 11:06:07 AM AI Chatbots Facing Tighter Rules Under New Laws By Alison Llewellyn Simon Bollans The UK’s approach to regulating AI chatbots is shifting rapidly in an effort to keep pace with technological change and address the risks...
5/11/2026 3:12:39 PM EU Digital Omnibus Deal: Simplification of AI Act and Postponed Deadlines By Simon Bollans Katie Hewson Alison Llewellyn On 7 May 2026, the European Parliament and the Council of the European Union reached a provisional political agreement under the European...
4/30/2026 2:28:55 PM The European Data Protection Board Releases New Guidelines on the Processing of Personal Data for Scientific Research By Katie Hewson Alison Llewellyn On 15 April 2026, the European Data Protection Board (the "EDPB") adopted draft Guidelines 1/2026 on processing of personal data for...
4/23/2026 10:19:39 AM FDA and EMA jointly issue guiding principles of good AI practice in drug development By Bobbie Bickerton Alison Llewellyn In January 2026, the FDA and the European Medicines Agency (the “EMA”) published a set of guiding principles for the use of AI across the...
4/23/2026 9:09:23 AM Court of Appeal ruling in RTM v Bonne Terre Ltd (trading as Sky Betting & Gaming) confirms an objective test for consent By Katie Hewson Alison Llewellyn On 21 April 2026, the Court of Appeal in RTM v Bonne Terre Ltd & Anor ([2026] EWCA Civ 488) clarified the standard for consent under UK...